Nervous System Disease: Clinical Trials

12 trials for Nervous System Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 1 active not recruiting, 1 recruiting. 2 Phase 1, 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 32Active not recruiting 1, Completed 1
Phase 21Completed 1

Follow Nervous System Disease: new trials by email Literature Review of Nervous System Disease trials Research Report on Nervous System Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 3 Study of NTLA-2001 in ATTRv-PN
nexiguran ziclumeran, Normal Saline as Placebo - Neuromuscular Disease, Neuromuscular Diseases (NMD)
Phase 3Active not recruitingIntellia Therapeutics672024-11-222026-11-05
Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
Nervous System Disease, Immune System Disease
RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)3502024-01-122026-08-05
PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of McCune-Albright Syndrome
Brain PET Imaging with 11C Rolipram, Whole Body PET Baseline with 11C Rolipram, Whole Body PET Blocked with Roflumilast - Nervous System Disease
Phase 1 / Phase 2CompletedNational Institute of Mental Health (NIMH)162018-04-042020-10-19
Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients
EryDex Low dose DSP, EryDex High dose DSP, Pooled Placebo - Nervous System Disease, Genetic Syndrome
Phase 3CompletedQuince Therapeutics S.p.A.1762017-03-022024-05-10
Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
Neoplasms, Nervous System Disease
CompletedNational Institute of Neurological Disorders and Stroke (NINDS)52010-09-222019-12-17
Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy
Healthy, Nervous System Disease
CompletedNational Institutes of Health Clinical Center (CC)4501997-07-012008-03-04
Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic Stimulation
Magstim Super Rapid Stimulator - Movement Disorder, Myoclonus
Phase 1CompletedNational Institute of Neurological Disorders and Stroke (NINDS)101997-01-012008-03-04
Sleep Disorders of Patients With Diseases of the Nervous System
Hypersomnia, Narcolepsy
CompletedNational Institute of Neurological Disorders and Stroke (NINDS)831996-12-042017-07-02
Diagnosis and History Study of Patients With Different Neurological Conditions
Nervous System Disease, Healthy Volunteer
CompletedNational Institute of Neurological Disorders and Stroke (NINDS)38131993-09-302026-11-09
Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders
Amnesia, Dementia
CompletedNational Institute of Neurological Disorders and Stroke (NINDS)8301992-12-012008-03-04
Magnetic Resonance Imaging Studies of Motor and Thought Processes
Cerebrovascular Disorder, Healthy
CompletedNational Institute of Neurological Disorders and Stroke (NINDS)6101992-10-012008-03-04
Genetic Studies in Alzheimer's Disease
Alzheimer's Disease, Nervous System Disease
CompletedNational Institute of Neurological Disorders and Stroke (NINDS)15001988-02-012008-03-04

Narrower conditions

Nervous System Diseases (12)  ·  Genetic Diseases, Inborn (2)  ·  Movement Disorders (2)  ·  Alzheimer Disease (1)  ·  Amnesia (1)  ·  Amyloid Neuropathies (1)  ·  Amyloid Neuropathies, Familial (1)  ·  Amyloidosis (1)  ·  Amyloidosis, Familial (1)  ·  Amyloidosis, Hereditary, Transthyretin-Related (1)  ·  Cerebrovascular Disorders (1)  ·  Dementia (1)  ·  Disorders of Excessive Somnolence (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Immune System Diseases (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (5)  ·  Central Nervous System Diseases (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Neurologic Manifestations (4)  ·  Signs and Symptoms (4)  ·  Brain Diseases (3)  ·  Mental Disorders (3)  ·  Genetic Diseases, Inborn (2)  ·  Neurocognitive Disorders (2)  ·  Neurodegenerative Diseases (2)  ·  Cardiovascular Diseases (1)  ·  Cranial Nerve Diseases (1)  ·  Cranial Nerve Neoplasms (1)  ·  Dementia (1)  ·  Dyskinesias (1)

Interventions

NTLA-2001 (1)  ·  Roflumilast (1)  ·  Saline Solution (1)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (7)  ·  Intellia Therapeutics (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  National Institute of Mental Health (NIMH) (1)  ·  National Institutes of Health Clinical Center (CC) (1)  ·  Quince Therapeutics S.p.A. (1)

Countries

United States (11)  ·  Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Germany (1)  ·  India (1)  ·  Israel (1)  ·  Italy (1)  ·  Mexico (1)  ·  Norway (1)  ·  Poland (1)  ·  Singapore (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Debra J Ehrlich, M.D. (1)  ·  Farinaz Safavi, M.D. (1)  ·  Guenter R. Janhofer, MD, PhD (1)  ·  John D Heiss, M.D. (1)  ·  Robert B Innis, M.D. (1)

Results publications

PMID 39152028, PMID 39917433

NIH funding

2015 (1)